Company · CIK 0001395937 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Syndax Pharmaceuticals Inc · SNDX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 SForm 4 → | Jul 9, 4:54 pm EDT | Michael A MetzgerChief Executive Officer, Director | 32,375 | $24.24 | $784,776 | 484,843 | −6.26% | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 9, 4:54 pm EDT | Michael A MetzgerChief Executive Officer, Director | 32,375 | $6.38 | $206,553 | 517,218 | — | 10b5-1 |
| Jun 11, 2026 SForm 4 → | Jun 12, 5:09 pm EDT | Nicholas A.J. BotwoodHead of R&D, CMO | 65,515 | $18.07 | $1,183,643 | 60,885 | −51.8% | 10b5-1 |
| Jun 11, 2026 MForm 4 → | Jun 12, 5:09 pm EDT | Nicholas A.J. BotwoodHead of R&D, CMO | 53,750 | $13.82 | $742,825 | 92,120 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 MForm 4 → | Jul 9, 4:54 pm EDT | Michael A MetzgerChief Executive Officer, Director | 32,375 | — | — | 0 | — | 10b5-1 |
| Jun 11, 2026 MForm 4 → | Jun 12, 5:09 pm EDT | Nicholas A.J. BotwoodHead of R&D, CMO | 53,750 | — | — | 0 | — | 10b5-1 |